Ulrika Nillroth

Cyclic HIV-1 Protease Inhibitors Derived from Mannitol:  Synthesis, Inhibitory Potencies, and Computational Predictions of Binding Affinities

Johan Hultén, Nicholas M. Bonham, Ulrika Nillroth et al. · Journal of Medicinal Chemistry · 1997 · 161 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design and Synthesis of New Potent<i>C</i>₂-Symmetric HIV-1 Protease Inhibitors. Use of<scp>l</scp>-Mannaric Acid as a Peptidomimetic Scaffold

Mathias Alterman, Magnus Björsne, Anna Mühlman et al. · Journal of Medicinal Chemistry · 1998 · 77 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

HIV-1 Protease Inhibitors Based on Acyclic Carbohydrates

Guido Zuccarello, Abderrahim Bouzide, Ingemar Kvarnström et al. · The Journal of Organic Chemistry · 1998 · 44 citations

Pharmacy, Biochemistry, Medicinal Chemistry +10

Synthesis of enantiomerically pure cis and trans 2-aminocyclopentanecarboxylic acids. Use of proline replacements in potential HIV-protease inhibitors

Daniel Nöteberg, Jonas Brånalt, Ingemar Kvarnström et al. · Tetrahedron · 1997 · 29 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study

Aylin Yilmaz, Dietmar Fuchs, Lars Hagberg et al. · BMC Infectious Diseases · 2006 · 26 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17